OSAM
KRYS icon

O'Shaughnessy Asset Management’s Krystal Biotech KRYS Stock Holding History

O'Shaughnessy Asset Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$635K Sell
1,708
-115
-6% -$34.4K ﹤0.01% 1484
2026
Q1 		$471K Sell
1,823
-600
-25% -$160K ﹤0.01% 1561
2025
Q4 		$597K Buy
2,423
+938
+63% +$197K ﹤0.01% 1400
2025
Q3 		$262K Buy
+1,485
New +$222K ﹤0.01% 1818
2025
Q2 		– Sell
-1,538
Closed -$277K – 2454
2025
Q1 		$277K Buy
+1,538
New +$259K ﹤0.01% 1628
2024
Q4 		– Sell
-1,425
Closed -$256K – 2246
2024
Q3 		$256K Buy
+1,425
New +$275K ﹤0.01% 1551

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

O'Shaughnessy Asset Management's KRYS Position: Q2 2026 in Review

O'Shaughnessy Asset Management reduced its Krystal Biotech (KRYS) stake by 6.3% in Q2 2026, selling an estimated $34.4K and leaving 1,708 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #1484.

O'Shaughnessy Asset Management first reported a position in KRYS in Q3 2024 and has held it in 6 quarters since. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • O'Shaughnessy Asset Management held 1,708 shares of Krystal Biotech worth $635K as of Q2 2026.
  • O'Shaughnessy Asset Management sold 115 Krystal Biotech shares in Q2 2026, an estimated $34.4K.
  • Krystal Biotech made up ﹤0.01% of O'Shaughnessy Asset Management's portfolio in Q2 2026, its #1484 holding.
  • O'Shaughnessy Asset Management first reported a position in Krystal Biotech in Q3 2024 and has held it in 6 quarters since.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on O'Shaughnessy Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.